Pharmaceutical Continuous Manufacturing Market

1. Download Report Sample

2. Pharmaceutical Continuous Manufacturing Market, by Product, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2019–2026," the global pharmaceutical continuous manufacturing market was valued at $393 million in 2018, and is expected to reach $855 million by 2026, growing at a CAGR of 10.2% from 2019 to 2026.   Continuous manufacturing is an advanced manufacturing approach to provide pharmaceutical products with enhanced quality, improved yield, reduced cost within shorter time period. Pharmaceutical continuous manufacturing market is expected to witness significant grow growth during the forecast period, due to increase in adoption of continuous manufacturing systems over the existing drug manufacturing process, technological advancements, initiatives taken by the Food and drug Administration (FDA) for promoting the use of pharmaceutical continuous manufacturing for modernizing pharmaceutical manufacturing, and advantage over the batch manufacturing. Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/6240 Pharmaceutical Continuous Manufacturing Market Download Report Sample

3. The global pharmaceutical continuous manufacturing market is segmented into product, application, end user, and region. Depending on product, the market is classified into integrated continuous systems, semicontinuous systems, and control & software. The applications covered in the study covered include final drug product manufacturing and API manufacturing. On the basis of end user, the market is categorized into pharmaceutical companies, contract manufacturing organizations, and others. Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, and rest of Europe), Asia-Pacific (China, Japan, India, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).  Depending on product, the integrated continuous systems segment hold the largest pharmaceutical continuous manufacturing market share in 2018, and is anticipated to exhibit significant growth during the forecast period. This is attributed to increase in adoption of integrated continuous manufacturing (ICM) process and availability of ICM systems.  Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/7882 Pharmaceutical Continuous Manufacturing Market Download Report Sample

4. North America accounted for approximately one-half of the global pharmaceutical continuous manufacturing market share in 2018, and is expected to remain dominant throughout the forecast period. This was attributed to higher adoption of pharmaceutical continuous manufacturing systems, increase in presence of pharmaceutical companies, availability of well-developed healthcare infrastructure, wide availability of advanced pharmaceutical continuous manufacturing systems, and supportive government policies for adoption of continuous manufacturing systems. However, Asia-Pacific is expected to experience fastest pharmaceutical continuous manufacturing market growth during the forecast period, majorly due to increase in adoption of pharmaceutical continuous manufacturing systems.  Customization request @ https://www.alliedmarketresearch.com/request-for-customization/7882 Pharmaceutical Continuous Manufacturing Market Download Report Sample

5. The Major Key Players Are: • Coperion GmbH • GEA Group AG • GEBRÜDER LÖDIGE MASCHINENBAU GMBH • Glatt GmbH • Hosokawa Micron Corporation • KORSCH AG • L.B. Bohle Maschinen + Verfahren GmbH • Munson Machinery Company, Inc • Robert Bosch Packaging Technology GmbH • Thermo Fisher Scientific, Inc Pharmaceutical Continuous Manufacturing Market Download Report Sample

6. Key Findings of the Study: • On the basis of product, the integrated continuous systems segment held more than 60% share in the global market in 2018. • By end user, the pharmaceutical companies segment exhibits fastest growth, and is expected to grow at a CAGR of 10.7% from 2019 to 2026.  • Depending on application, the final drug product manufacturing segment held largest market share in 2018, and is expected to remain dominant throughout the forecast period.  • Region wise, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 11.5% during the forecast period.  Pharmaceutical Continuous Manufacturing Market  Download Report Sample

7. Contact: David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free (USA/Canada): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Pharmaceutical Continuous Manufacturing Market Download Report Sample